Custom Surgical Eye Care in Yorkshire
Cataract Surgery with vision correction
Vitrectomy for floaters
Retinal surgery to improve distorted or blurred vision from macular hole, epiretinal membrane, retinal detachment, vitreomacular traction, diabetic retinopathy, subluxed or dislocated intraocular lens replacment, and more.....
Mr Simon Kolb
Consultant Ophthalmologist, Cataract and Vitreoretinal Surgeon
Coronavirus Update (20/10/2020):
Hospital changes are occuring rapidly in response to the fluctuating spread of COVID-19. Waiting times for clinic and theatre are likley to be impacted both in the NHS and Private sector.
Measures have been made to the hospitals to ensure hygeine, safe social distancing, pre-screening and testing to make your appointments and treatments as safe as possible.
Mr Kolb is a consultant Ophthalmologist who specialises in Vitreous, Retinal and Cataract surgery.
He graduated from Newcastle University before obtaining a national training number in Ophthalmology. He has gained a wealth of experience working at different hospitals across the United Kingdom and New Zealand. He has gained advanced sub specialty training in Vitreoretinal surgery at Europe's largest teaching hospital, St James University Teaching Hospital in Leeds.
He now works at St James University Hospital as a consultant Vitreoretinal surgeon and honorary senior lecturer at the University of Leeds. Passionate about the continued development of training new surgeons, Mr Kolb is the royal college tutor at St James, looking after the education and support of new ophthalmic trainees. He also works weekly at the Yorkshire Eye Hospital in Bradford and the Spire Leeds Hospital in Roundhay.
Mr Kolb is avidly engaged in research, having published many articles in international journals, including the British journal of Ophthalmology, the British Medical Journal and the Journal of Cataract and Refractive Surgeons. He has also presented at national and international conferences. He is enrolled to start work in a multinational project investigating the novel treatment of sub retinal gene therapy for inherited retinal conditions.